4//SEC Filing
INNOVUS PHARMACEUTICALS, INC. 4
Accession 0001415889-16-004589
CIK 0001411879operating
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:08 PM ET
Size
5.8 KB
Accession
0001415889-16-004589
Insider Transaction Report
Form 4
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
- Award
Restricted Stock Unit
2016-01-29+4,000,000→ 5,875,000 total→ Common Stock (4,000,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit award on January 29, 2016 of 4,000,000 shares, of which 4,000,000 vested immediately.
- [F3]These restricted stock units vested 100% on January 29, 2016
- [F4]These restricted stock units were granted pursuant to the Issuer's 2014 Equity Incentive Plan.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001411879
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 6:08 PM ET
- Size
- 5.8 KB